Metabolic profiling of EC cells revealed higher rates of glycolysis and lower glucose oxidation, and tumor cells may rely on GLUT6-mediated glucose transport and glycolytic–lipogenic metabolism for survival [26]. This evidence concerns the gene SLC2A6 and neoplasm.